Dark

CRVS
Corvus Pharmaceuticals, Inc.
stock NASDAQ

Market Open

Aug 5, 2026 3:30:31 PM EDT

13.82USD-0.790%(-0.11)366,588

13.80Bid 13.82Ask 0.02Spread

Pre-market

Aug 3, 2026 9:27:30 AM EDT

13.31USD-0.449%(-0.06)0

After-hours

Aug 4, 2026 4:00:30 PM EDT

13.92USD-0.072%(-0.01)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

1.16B

CEO

Richard Miller

Headquarters

Burlingame, California, USA

Industry

Biotechnology

Next Earnings

Aug 6, 2026 (1d)

OMER XLV

CRVS Stats

Avg. Vol. 10 Day

791,638

Avg. Vol. 30 Day

1,182,730

Employees

Market Cap

1,164,131,012

Shares Out.

84,090,424

On/Off Exchange

66%/34%

6 Month Beta

1.95

1 Year Beta

-0.51

2 Year Beta

0.79

3 Year Beta

1.03

52 Week Low

4.05

52 Week High

26.95

SMA50

13.30

SMA200

13.03

1 Week

+6.16%

1 Month

-8.74%

3 Month

-11.82%

6 Month

-27.37%

1 Year

+222.70%

2 Year

+390.92%

5 Year

+592.19%

Profile

corvus pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. with accomplished and talented scientists, and top-tier investors, we are well positioned in an exciting new era of immuno-oncology.

CRVS Stock Summary

Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) stock price today is $13.82, and today's volume is 366,588. CRVS is down -0.790% today. The 30 day average volume is 1,182,730. CRVS market cap is 1.16B with 84,090,424 shares outstanding.

.dark-mode .ccmH44{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .ccmH44{ color: #333333; background-color: white; border: 2px solid #333333; }CRVSCorvus Pharmaceuticals, Inc.stock NASDAQ

CRVS Stock Summary

CRVS
Corvus Pharmaceuticals, Inc.
stock NASDAQ